What Would Disqualify You From Donating a Kidney? 2026 Guide

What would disqualify you from donating a kidney depends on why the transplant team believes donation may be unsafe for you, unsafe for the recipient, medically inappropriate or inconsistent with the legal and ethical requirements of living donation. Some conditions are clear exclusions under particular transplant policies. Others are temporary, treatable or assessed individually according to age, kidney function, blood pressure, metabolic health and predicted lifetime risk.

Common reasons a potential living kidney donor may not be accepted include significant kidney disease, inadequate kidney function, persistent high-risk urine abnormalities, uncontrolled hypertension, certain forms of diabetes, active or incompletely treated cancer, serious infection, unacceptable surgical risk, some inherited kidney disorders, significant psychosocial concerns, coercion or illegal financial inducement.

However, many findings that people assume are automatic disqualifiers—such as being overweight, taking one blood-pressure medicine, having had a kidney stone many years ago or having a remote history of certain cancers—may require individualized assessment rather than an immediate “no.”

That distinction matters.

The purpose of donor screening is not to find the healthiest human being possible. It is to determine whether removing one kidney leaves that particular person with an acceptably low short- and long-term health risk.

Patients considering a kidney transplant should therefore avoid assuming that a willing relative or spouse is already an approved donor until the authorized transplant team has completed the required evaluation.

What would disqualify you from donating a kidney? Quick answer

What would disqualify you from donating a kidney can include inadequate kidney function, significant kidney disease, uncontrolled hypertension, type 1 diabetes under current U.S. OPTN policy, certain high-risk cases of type 2 diabetes, active or incompletely treated cancer, unresolved symptomatic infection, unsafe surgical or cardiovascular risk, uncontrolled psychiatric illness, coercion or illegal payment. Other issues—including obesity, controlled hypertension, previous kidney stones or some past cancers—may be evaluated individually rather than automatically disqualifying a donor. Final eligibility depends on the transplant center's complete medical, psychosocial, surgical and legal assessment.

What disqualifies you from donating a kidney is not always permanent

One of the most useful distinctions for potential donors is the difference between permanent exclusion, temporary deferral and individualized assessment.

People often receive one abnormal result and immediately assume donation is impossible. In other cases, families assume a health problem is minor and can simply be ignored.

Both reactions can be wrong.

Some conditions create a risk that is unlikely to become acceptable. Significant chronic kidney disease is an obvious example.

Other problems may temporarily stop donation. An acute infection, for example, may need to be treated before evaluation continues.

A third group falls into a gray zone. Controlled hypertension, obesity, previous kidney stones and some previous cancers may be approached differently depending on the donor's complete health profile and the transplant program's acceptable-risk threshold.

Current OPTN policy gives transplant hospitals the authority to exclude any donor whom the program considers medically unsuitable and also identifies specific mandatory exclusions. KDIGO takes a complementary approach by emphasizing comprehensive lifetime-risk assessment rather than decisions based on one factor alone.

This is why different reputable centers can occasionally reach different decisions about borderline candidates without either center necessarily being wrong.

Why transplant teams are stricter with donors than ordinary patients

A potential kidney donor may reasonably ask:

“My doctor says I'm healthy, so why might the transplant team reject me?”

The answer lies in the ethical difference between ordinary healthcare and living donation.

A person undergoing surgery for their own illness may accept substantial risk because the treatment offers them a direct medical benefit.

A living kidney donor is different.

The donor undergoes major surgery primarily to benefit another person. The donor begins the process healthy enough not to need nephrectomy for their own medical treatment.

The acceptable risk threshold must therefore be low.

A mild health problem that would be managed routinely in the general population can carry more significance when doctors are considering permanently removing approximately half of the person's renal mass.

A transplant program is therefore not merely asking whether the donor is currently healthy.

It is asking whether the donor is likely to remain acceptably healthy with one kidney for decades.

That requires assessment of kidney reserve, future diabetes and hypertension risk, cardiovascular health, inherited disease, pregnancy considerations, surgical risk and lifestyle factors.

KDIGO explicitly recommends evaluating the combined demographic and health profile rather than treating individual characteristics in isolation.

Kidney disease can disqualify a living kidney donor

This is one of the clearest categories.

A person whose kidneys already show clinically important disease may not have enough renal reserve to safely lose one kidney.

The problem is not simply whether the potential donor needs dialysis today.

Early kidney disease may be asymptomatic.

The donor may feel completely well while laboratory or urine tests reveal evidence that the kidneys are already under stress.

Evaluation therefore looks at several dimensions of renal health: filtration, urine albumin, blood or protein in the urine, anatomical findings, family history, stone risk and possible inherited kidney disorders.

Our conditions library includes diseases such as polycystic kidney disease and diabetic kidney disease, both of which illustrate why apparently healthy relatives may sometimes need additional renal assessment before donation.

A donor candidate with established significant chronic kidney disease would generally not be considered appropriate because nephrectomy would deliberately reduce the remaining kidney reserve.

How low kidney function can disqualify you

Kidney donor assessment uses glomerular filtration rate, or GFR, because serum creatinine alone does not adequately describe renal filtering capacity.

KDIGO recommends estimating GFR initially and confirming it using an appropriate method when necessary. The guideline gives three broad decision ranges.

These thresholds do not mean a GFR above 90 automatically makes someone eligible.

They answer only one component of donor evaluation.

A person can have excellent GFR and still be unsuitable because of significant albuminuria, uncontrolled hypertension, an inherited disease, unsafe anatomy or another risk.

Similarly, a GFR of 82 is not an automatic rejection.

Age changes interpretation. An otherwise healthy older potential donor with a stable GFR in the 80s may have a very different risk profile from a much younger candidate with the same result plus obesity, hypertension and strong familial kidney-disease risk.

The transplant nephrologist assesses the whole picture.

Protein or albumin in the urine can be a warning sign

Albuminuria can indicate kidney damage before a person develops symptoms.

This is why a routine blood creatinine result cannot establish donor suitability by itself.

KDIGO recommends measuring urinary albumin as part of living donor evaluation. It considers an albumin excretion rate below 30 mg/day generally acceptable, recommends individualized assessment between 30 and 100 mg/day, and advises against donation above 100 mg/day.

These values require clinical interpretation.

One abnormal urine sample does not necessarily prove permanent kidney disease. Exercise, fever and other temporary circumstances can sometimes affect urine results.

Persistent abnormality is different.

If albumin remains elevated, the transplant team needs to understand the underlying cause before donation can be considered safe.

Blood in the urine can delay or prevent donation

Microscopic hematuria—blood in the urine that may not be visible—can arise for many reasons.

Some causes are temporary or relatively minor.

Others can signal kidney stones, urinary-tract disease, inherited disorders or glomerular kidney disease.

KDIGO recommends investigating persistent microscopic hematuria before living kidney donation.

The important word is persistent.

A temporary finding may disappear on repeat testing.

A repeated unexplained abnormality needs investigation.

The transplant team may request additional urine studies, imaging, specialist evaluation or other testing depending on the donor's age and medical history.

If the cause represents an important kidney disease or unacceptable future risk, donation may no longer be appropriate.

High blood pressure: when does hypertension disqualify a kidney donor?

Hypertension is one of the most frequently misunderstood donor issues.

A single high reading does not necessarily disqualify someone.

At the same time, significant hypertension cannot be dismissed because high blood pressure is both a cardiovascular risk factor and a major cause of kidney disease.

Current U.S. OPTN exclusion criteria require kidney recovery hospitals to exclude donors with uncontrollable hypertension or a history of hypertension accompanied by evidence of end-organ damage.

KDIGO is somewhat more detailed in its clinical approach. It states that selected donor candidates whose blood pressure can be controlled below 140/90 mmHg using one or two antihypertensive medications and who have no target-organ damage may be considered individually according to the transplant program's acceptable-risk threshold.

This distinction explains why “I take a blood-pressure tablet” does not produce a universal yes or no.

The transplant team considers how long hypertension has been present, how severe it is, how many medications are required, whether urine albumin is elevated, whether the heart or blood vessels show damage, the donor's age and whether other metabolic risks are present.

A young person with difficult-to-control hypertension and albuminuria is not equivalent to an older otherwise healthy candidate with stable mild hypertension controlled on one medication.

Ambulatory blood-pressure monitoring may sometimes be used when clinic readings do not clearly establish the diagnosis.

Diabetes: a major kidney donor issue

Diabetes deserves particular caution because it can cause chronic kidney disease, cardiovascular disease and vascular complications.

Current OPTN policy requires exclusion of living kidney donors with type 1 diabetes. It treats type 2 diabetes differently: a candidate must be excluded when individualized assessment identifies end-organ damage or an unacceptable lifetime risk of complications.

That does not mean type 2 diabetes is routinely accepted.

Many transplant programs remain cautious, particularly in younger candidates or those with additional risk factors.

Consider two potential donors.

One is young and has type 2 diabetes, obesity, hypertension and early albuminuria.

Another is considerably older, has very well-controlled type 2 diabetes, no albuminuria, normal renal function and no diabetic complications.

Even where regulations permit individualized assessment, those two candidates do not have the same lifetime risk.

Prediabetes can also matter.

Fasting glucose, HbA1c, family history, previous gestational diabetes, weight and metabolic profile can all help the team assess the likelihood that a donor will develop significant diabetes after nephrectomy.

For more background on how diabetes can affect kidney health, see our guide to diabetic kidney disease.

Kidney donor weight requirements: can BMI disqualify you?

Kidney donor weight requirements are one of the most common reasons people become confused by information online.

There is no single global BMI cutoff used by every transplant center.

KDIGO recommends calculating BMI and evaluating donor candidates with BMI above 30 kg/m² individually in relation to their demographic and health profile and the program's acceptable-risk threshold.

Individual hospitals may set stricter thresholds.

That means a BMI of 31 does not carry an automatic universal outcome.

One program may request weight loss before reconsidering donation. Another may evaluate the candidate if there are no other metabolic problems. A person with severe obesity plus hypertension and prediabetes is likely to be viewed differently from someone with mildly elevated BMI and otherwise excellent metabolic health.

Why does weight matter?

The concern is not cosmetic.

Obesity can increase surgical complexity and is associated with future hypertension, type 2 diabetes, cardiovascular disease and chronic kidney disease.

When one kidney is being permanently removed, those long-term risks become especially relevant.

A potential donor who is asked to lose weight should therefore not interpret that request as punishment or arbitrary bureaucracy.

It can be an attempt to reduce surgical and long-term risk.

At the same time, weight-loss targets should come from the transplant team rather than from an internet formula designed for the general population.

Can cancer patients donate organs?

The secondary question can cancer patients donate organs needs careful wording because “cancer patient” can mean very different things.

A person with active cancer currently requiring treatment is not the same as someone who had a small, low-risk cancer successfully treated many years ago.

Under current OPTN living-donor exclusion criteria, active malignancy or incompletely treated malignancy must exclude donation when it requires treatment other than surveillance or carries more than minimal known risk of transmission to the recipient.

Why is cancer important in living kidney donation?

There are two separate concerns.

The first is the donor.

If cancer recurs, future treatment may be complicated by reduced renal reserve after nephrectomy. Some chemotherapy and other therapies can affect kidney function.

The second concern is the recipient.

A transplanted organ can, in rare circumstances, transmit malignant cells. That risk is particularly serious because transplant recipients take immunosuppressive medications.

A history of cancer therefore requires individualized assessment of cancer type, stage, treatment, time since treatment, recurrence risk and transmission risk.

The answer to “I had cancer—is donation impossible?” is therefore not universally yes.

The answer to “I have active cancer and am currently receiving treatment—can I simply donate anyway?” is generally no within responsible living-donor practice.

The transplant center and, when appropriate, oncology specialists need to assess the case.

Infection can temporarily disqualify a donor

Current OPTN criteria require exclusion of donors with evidence of an acute symptomatic infection until it has resolved.

That wording is important.

“Until resolved” means some infection-related exclusions are temporary rather than permanent.

A respiratory or urinary infection shortly before planned evaluation does not necessarily mean the person can never donate.

It means elective donor surgery should not move forward while the infection creates unnecessary risk.

Other infections require a more specialized assessment because they could be transmitted to an immunosuppressed recipient or indicate a significant health problem.

In 2026, HRSA updated OPTN living-donor infectious-disease requirements, including changes relating to HIV and West Nile virus testing windows and seasonal West Nile virus screening. The OPTN policy page was updated on August 17, 2026.

This is a useful example of why donor candidates should rely on the transplant center's current testing protocol rather than an old checklist found online.

For international donors, infection screening may also reflect country of residence and travel history.

Different geographic exposures can justify additional testing.

HIV is no longer a simple universal yes-or-no statement

Older websites often describe HIV infection as an absolute living-donor exclusion without qualification.

That can now be outdated.

U.S. transplant policy has evolved, including specific regulated pathways related to transplantation involving donors and recipients living with HIV. The HRSA policy page documents the 2025 revisions aligning HIV policies with federal regulatory updates.

This does not mean HIV-positive living kidney donation is routine.

It means the subject requires specialist evaluation under the applicable legal and policy framework rather than a blanket statement copied from older guidance.

For SEO and patient education, this distinction matters.

A trustworthy article should not turn a complex regulated pathway into an outdated “always impossible” claim.

Kidney stones do not always disqualify a donor

A history of kidney stones is another example of a finding that may require investigation rather than automatic rejection.

The key questions are why the stone formed, whether stones are recurrent, whether stones are present in both kidneys, whether imaging shows current stones and whether metabolic testing indicates a high risk of future recurrence.

A person who had one isolated stone many years ago may have a different risk profile from someone who forms stones repeatedly.

Why does the transplant team care so much?

After donation, the person will have one kidney.

Obstruction, infection or recurrent stone disease in that remaining kidney can become more consequential.

KDIGO recommends reviewing stone history and kidney imaging. Current OPTN policy also requires additional metabolic testing for selected donor candidates with nephrolithiasis history or stones identified on imaging.

A kidney stone should therefore be disclosed even if the donor has not experienced symptoms for years.

Trying to hide it may delay evaluation later when imaging reveals the history anyway.

Recurrent urinary infections can require further investigation

Repeated urinary tract infections do not necessarily disqualify a donor, but they can raise questions about urinary anatomy, kidney infections or other underlying problems.

An isolated bladder infection years ago is usually a very different scenario from recurrent pyelonephritis involving the kidneys.

The donor team needs to understand the pattern.

If recurrent infections reflect a structural problem that may threaten the remaining kidney after donation, the risk becomes more important.

In many cases the issue is not the infection itself but what the infection may reveal.

This is a recurring theme throughout living donor evaluation.

The team is often less interested in the label than in its cause and its predicted consequences after nephrectomy.

Inherited kidney disease can disqualify a related donor

Family members frequently assume that biological relationship makes them ideal donors.

Sometimes it improves immunological compatibility.

But biological relationship can also create shared genetic risk.

If the recipient developed kidney failure because of an inherited disease, a sibling, adult child or parent may carry the same disease even if they have not yet developed symptoms.

Polycystic kidney disease is one example.

Other inherited renal disorders can create similar concerns.

The younger the donor, the more challenging this can become because some inherited kidney diseases may not yet have produced obvious abnormalities.

Transplant teams therefore review both the recipient's diagnosis and the donor's family history.

Genetic testing may be appropriate in selected situations, but it is not automatically required for every donor.

The key question is whether the potential donor could be at meaningful risk of developing the same disease later.

Removing one kidney from someone with a substantial inherited renal risk would be difficult to justify.

Serious cardiovascular disease can make donor surgery unsafe

Living kidney donation requires general anesthesia and major abdominal surgery.

Excellent kidney function does not guarantee that a person is safe for surgery.

The transplant team therefore assesses cardiovascular and pulmonary risk according to age, medical history and symptoms.

Someone with unstable or severe cardiovascular disease may face an unacceptable perioperative risk even if the kidneys themselves appear healthy.

KDIGO recommends using established preoperative approaches for noncardiac surgery rather than automatically performing extensive cardiac testing in every healthy donor.

This means testing is tailored.

A young asymptomatic candidate may not require the same cardiac assessment as an older person with diabetes, previous chest pain or known vascular disease.

The principle remains donor safety.

If a serious heart or vascular problem is discovered during evaluation, treating that condition becomes more important than proceeding with donation.

Lung disease and other major illnesses may affect eligibility

The same logic applies outside the cardiovascular system.

Severe pulmonary disease, significant liver disease, major clotting disorders and other serious medical conditions can influence surgical or long-term risk.

There is no useful internet list that can cover every possible diagnosis.

Transplant programs therefore review the donor's entire medical history.

An important point for potential donors is that “I feel fine” and “I can safely undergo elective nephrectomy” are not identical statements.

The evaluation may discover a condition that requires treatment even if donation never proceeds.

In that sense, donor assessment sometimes identifies health issues that benefit the potential donor independently of the transplant.

Pregnancy itself prevents immediate donation

A person who is currently pregnant cannot undergo elective living kidney donation during pregnancy.

That is different from saying that someone who wants children in the future is disqualified.

Future pregnancy is not an automatic exclusion.

However, women considering donation should receive counseling about pregnancy-related risk after nephrectomy.

Evidence suggests gestational hypertension and preeclampsia can occur more frequently after kidney donation than in comparable healthy women who have not donated.

The donor's prior pregnancy history also matters.

Previous preeclampsia, gestational hypertension or gestational diabetes can influence assessment because these conditions may indicate future cardiovascular, metabolic or kidney risk.

The correct approach is therefore individualized counseling rather than telling women that donation permanently prevents pregnancy.

Mental-health conditions do not automatically disqualify everyone

Psychological assessment is sometimes misunderstood as an attempt to find a reason to reject donors.

That is not its purpose.

Living donation creates emotional, family and social pressures that do not appear on blood tests.

A potential donor needs the capacity to understand the decision, realistic expectations about outcomes and adequate ability to cope with surgery and recovery.

Current OPTN exclusion criteria require exclusion when there is an uncontrolled diagnosable psychiatric condition requiring treatment before donation, including evidence of suicidality.

That wording does not mean every person who has ever experienced depression or anxiety is automatically excluded.

A stable, appropriately treated mental-health condition may be very different from an acute uncontrolled disorder.

The psychosocial evaluator considers severity, stability, treatment, decision-making capacity, support and whether donation could worsen the person's condition.

HRSA guidance also specifically recognizes psychosocial evaluation as a core part of informed living donation.

Coercion can disqualify a donor even when every medical test is normal

A person can have perfect kidney function and still be an unacceptable living donor if the decision is not truly voluntary.

Current OPTN policy requires exclusion when there is high suspicion of donor inducement, coercion or other undue pressure.

This protection is critical in family transplantation.

Pressure does not always look dramatic.

A donor may feel that refusing would mean letting a parent die.

A spouse may believe the marriage will be damaged if they decline.

A sibling may be repeatedly told that they are the only suitable person.

A family may already have spent money on flights and accommodation, making the donor feel unable to withdraw.

These pressures can undermine genuine consent.

A responsible transplant pathway therefore needs the donor to have an opportunity to speak independently with professionals responsible for protecting donor interests.

The donor retains the right to change their decision.

Illegal payment is a disqualifying ethical and legal issue

Living organ donation cannot be treated as the commercial purchase of a kidney.

Current OPTN policy excludes donors when there is high suspicion of knowingly and unlawfully transferring something of value in exchange for a human organ.

This distinction is especially important for international transplantation.

Legitimate reimbursement of permitted expenses is not the same as buying an organ.

National laws determine what forms of expense reimbursement are allowed.

But a transplant program should never present the kidney itself as a product with a purchase price.

Organ Transplant Abroad's ethical sourcing policy reflects this distinction and should remain a central internal link on donor-related content.

The platform's role is to help organize a lawful clinical pathway for patients who already have an identified potential donor—not to source, broker, purchase or sell organs.

Smoking: does it automatically disqualify you?

Smoking is not universally listed as an automatic kidney-donor exclusion, but it matters.

Smoking increases cardiovascular and pulmonary risk, affects wound healing and contributes to long-term disease.

KDIGO recommends that donor candidates who smoke stop at least four weeks before donation to reduce perioperative complications and encourages long-term cessation.

Individual centers may impose their own requirements.

A person who smokes heavily and also has cardiovascular disease, hypertension or other risk factors may face a very different assessment from an otherwise healthy candidate.

The appropriate response is not to hide tobacco use.

Accurate disclosure allows the team to estimate surgical and long-term risk and provide cessation support where appropriate.

Alcohol and recreational drug use

Alcohol use is evaluated in context.

Occasional alcohol consumption is not equivalent to a substance-use disorder.

The concern becomes greater when use is uncontrolled, creates liver or cardiovascular disease, interferes with decision-making or raises questions about recovery and adherence to follow-up.

Recreational drug use is similarly assessed according to substance, frequency, dependence, medical consequences and psychosocial stability.

The donor team is not conducting a moral judgment.

It is evaluating whether donation and recovery can occur safely and whether informed consent is reliable.

Being honest during evaluation is therefore essential.

A hidden substance-use problem that later emerges can interrupt the donor pathway and damage trust between the donor and transplant team.

Does being an organ donor put you at risk?

The question does being an organ donor put you at risk needs an important distinction.

Registering as a deceased organ donor does not expose you to kidney-removal surgery while you are alive. The donation occurs only after death has been formally established under the applicable medical and legal process.

Living kidney donation is different.

A living donor voluntarily undergoes surgery and therefore accepts real, although generally low, medical risks.

A contemporary JAMA study examined 164,593 U.S. living kidney donors between 1993 and 2022. Perioperative mortality declined substantially over time; during 2013–2022 it was fewer than one death per 10,000 donations.

That is reassuring.

But “very low risk” is not the same as “no risk.”

Living donors can experience bleeding, infection, blood clots, anesthesia complications, pain and other surgical complications.

Long-term concerns include reduced renal reserve and a small increase in the absolute risk of kidney failure compared with similarly healthy people who keep both kidneys.

This is exactly why donor screening is strict.

The evaluation is intended to keep those risks as low as reasonably possible.

Does being rejected mean something is medically wrong with you?

Not necessarily.

Living donor standards are different from ordinary definitions of health.

A person may be healthy enough to work, exercise, travel and live normally yet still not meet a transplant program's threshold for elective nephrectomy.

For example, a mild combination of obesity, borderline blood pressure and family history of diabetes might not make someone “sick.”

But when the transplant team asks what that person's kidney risk could look like 30 years after losing one kidney, the decision can become more conservative.

This is why donors should not interpret rejection as a declaration that they are unhealthy or defective.

It means the program believes the risk-benefit balance does not justify nephrectomy.

In some cases the evaluation identifies an actual health issue that deserves medical follow-up.

That information can be valuable to the donor even though the donation does not proceed.

Conditions that may be temporary rather than permanent

Potential donors often benefit from understanding which problems may be revisited.

The existence of a potentially reversible factor does not guarantee later approval.

It means the transplant program needs more information or a lower-risk clinical situation before deciding.

Kidney anatomy can make surgery difficult even when the donor is healthy

Laboratory tests do not show the full anatomy of the kidneys.

Imaging may reveal multiple renal arteries, unusual veins, kidney asymmetry, cysts, masses, stones or collecting-system abnormalities.

Some of these findings are compatible with donation.

Others can make donor nephrectomy unnecessarily difficult or leave the donor with the less suitable kidney.

KDIGO recommends assessing renal imaging carefully and, when abnormalities exist but do not completely prevent donation, prioritizing long-term donor safety when deciding which kidney should remain.

This is why a potential donor should not be declared “cleared” before anatomical imaging has been reviewed by an experienced donor surgeon.

The medical evaluation and surgical evaluation are related but distinct.

Compatibility problems are not the same as donor disqualification

A donor can be perfectly healthy yet not be an appropriate direct match for the intended recipient.

This should be described as incompatibility, not necessarily donor medical disqualification.

Blood type, HLA information, recipient antibodies and crossmatching can affect whether direct transplantation is feasible.

In some healthcare systems, incompatible donor-recipient pairs may enter kidney paired donation or another regulated pathway.

NHS Blood and Transplant explains that the UK national living donor kidney sharing scheme can provide options when a willing donor is medically suitable but not compatible with the intended recipient.

Whether a similar option exists for an international patient depends on the destination country's law and transplant infrastructure.

This matters because families sometimes abandon a medically suitable donor after hearing “not compatible” when the true issue is the specific donor-recipient pairing rather than the donor's health.

A donor can also be medically eligible but legally ineligible

International transplantation introduces another distinction.

Medical suitability and legal eligibility are not the same.

A potential donor can have excellent kidneys, ideal anatomy and acceptable compatibility yet still be unable to proceed if the proposed donation does not satisfy the country's legal requirements.

This is particularly relevant for people researching kidney transplant abroad.

Countries regulate living donation differently.

Some permit broader categories of unrelated donation. Others impose specific relationship documentation or ethics review.

Therefore, before a patient commits to travel, both questions need answers:

Is this donor medically suitable?

Is this donor-recipient relationship legally permitted through the intended pathway?

A medical coordinator should never promise that the first answer automatically guarantees the second.

What can disqualify a kidney donor in Türkiye?

For patients considering Kidney Transplant in Turkey, Türkiye has both a national living kidney donor clinical protocol and a formal organ-transplant regulation.

The Turkish Ministry of Health currently lists Böbrek Nakli Canlı Donör Seçimi ve Yaşam Boyu Takip Klinik Protokolü, the Living Kidney Donor Selection and Lifelong Follow-Up Clinical Protocol, as an official resource. The Ministry's transplant regulations page was updated in 2026 and continues to list the Organ Transplant Services Regulation.

This means a donor can fail the Turkish pathway for more than one type of reason.

The Turkish regulation allows living organ transplantation from a spouse—generally where the marriage has existed for at least two years—and from blood or in-law relatives through the fourth degree. It provides an exception to the two-year marriage condition when the transplant-requiring disease was diagnosed after marriage.

Cases outside those standard relationship categories require assessment by the Organ Transplant Evaluation Ethics Commission.

The regulation also states that certain people residing in Türkiye under the foreigner/international-protection framework undergo ethics-commission assessment even when donor and recipient are related, and it permits the Ministry to require ethics review or additional restrictions for health-tourism cases from areas considered at risk for organ trafficking.

The practical message is important:

A potential donor may be medically acceptable but still require additional legal and ethics review before transplantation in Türkiye.

Medical disqualification vs Turkish ethics rejection

These should not be presented to patients as if they are the same decision.

If a transplant nephrologist determines that a donor has unsafe kidney function, that is a medical donor-safety decision.

If an ethics commission determines that the proposed relationship or circumstances do not satisfy the regulatory framework, that is a legal or ethical pathway decision.

Both can prevent transplantation.

But they have different reasons and different next steps.

This distinction becomes especially important when patients travel internationally.

A coordinator who tells a family only “your donor was rejected” without explaining whether the issue was medical, compatibility-related or regulatory is not giving them enough information to understand the case.

Why documents matter before travelling abroad

International patients can reduce avoidable delays by organizing complete donor and recipient records before travel.

Our documents to prepare for transplant treatment abroad guide can help families structure the file.

Medical history should be complete rather than selectively reassuring.

If the potential donor has had kidney stones, hypertension, diabetes, cancer, significant infection, major surgery or another relevant diagnosis, that information should be included.

Submitting only normal results can backfire.

Imaging or laboratory testing performed after arrival may reveal the omitted history anyway, creating delays and undermining the transplant team's confidence in the file.

Relationship documentation may also be relevant for countries such as Türkiye.

The exact documents should come from the authorized transplant center because requirements vary by nationality, donor relationship and regulatory pathway.

Should you travel before the donor has been reviewed?

Usually, the safer sequence is preliminary review first and travel planning second.

A transplant center may not be able to give final donor approval remotely because imaging, compatibility testing and other investigations often need to be completed or verified locally.

But a preliminary document review can still identify major concerns.

For example, a donor with established advanced kidney disease is unlikely to benefit from flying internationally simply to discover the same exclusion after arrival.

Likewise, a relationship that clearly requires an ethics pathway should be identified before the family assumes surgery can occur immediately.

The goal of remote review is not to replace formal donor evaluation.

It is to avoid unnecessary travel and to identify what remains unresolved.

Can you change transplant centers after being disqualified?

Sometimes a second opinion can be reasonable.

Transplant programs can differ in their acceptance thresholds for borderline risks such as obesity, controlled hypertension or certain previous cancers.

However, there is an important difference between seeking a second opinion and shopping for someone willing to ignore a serious risk.

If one center identifies significant kidney disease, another center needs to see that information.

If a donor has been rejected because of coercion or illegal payment concerns, the solution is not to conceal those circumstances elsewhere.

A second opinion should clarify uncertainty.

It should not be used to bypass donor protection.

In Türkiye, the regulatory framework is even clearer in certain ethics cases: the Organ Transplant Evaluation Ethics Commission regulation states that another commission cannot approve an application that has been found unsuitable by a commission under the applicable process.

That makes accurate understanding of the original decision particularly important.

What happens if one abnormal test appears during evaluation?

One abnormal result often triggers investigation rather than immediate permanent rejection.

Suppose a urine sample shows protein.

The team may repeat it.

Suppose blood pressure is high in clinic.

Ambulatory monitoring may help determine whether the person truly has sustained hypertension.

Suppose creatinine produces an uncertain estimated GFR.

Measured GFR or another confirmatory approach may be used.

Suppose imaging reveals a small kidney lesion.

Further characterization may be required before anyone can determine whether it matters.

This is why donors should avoid interpreting isolated test values without clinical context.

A transplant assessment is a process.

The final decision should be based on the best available explanation of the donor's health rather than on one unexplained number.

What if a donor is asked to lose weight first?

A request for weight loss usually means the center is trying to lower risk before making a final decision.

It does not necessarily mean the donor is permanently disqualified.

Depending on the program, reassessment may occur after a target is reached and weight is stable.

But weight alone may not be the only issue.

If obesity occurs alongside diabetes, hypertension, sleep apnea, fatty liver disease or other metabolic problems, losing several kilograms does not automatically erase the underlying risk profile.

The donor team may reassess blood pressure, glucose control and other indicators after weight loss.

This is another reason kidney donor weight requirements should not be reduced to a single BMI number.

The clinical question is what the donor's overall metabolic and surgical risk looks like after optimization.

What if blood pressure improves?

The same principle applies to hypertension.

If elevated blood pressure was caused partly by weight, stress or an untreated condition, improving those factors may change the assessment.

However, a history of hypertension remains part of the medical record.

The transplant team may still need to understand how long the condition has existed and whether it caused kidney, heart or vascular damage.

Controlled blood pressure is more reassuring than uncontrolled blood pressure.

But the complete risk profile still matters.

Can medication itself disqualify a donor?

Usually, the medication is less important than the condition it treats.

Taking an antihypertensive drug tells the transplant team that blood pressure history needs assessment.

Taking glucose-lowering medication indicates diabetes or another metabolic issue.

Long-term anti-inflammatory medication use might raise kidney concerns depending on the drug and pattern.

Anticoagulation can affect surgical planning and may reflect a clotting or cardiovascular disorder.

The donor should therefore provide a complete medication list rather than stopping medication independently to appear healthier during assessment.

Stopping prescribed medication without medical supervision can be dangerous and can make the evaluation less accurate.

What about autoimmune disease?

Autoimmune diseases vary enormously.

Some primarily affect one organ. Others can involve the kidneys, blood vessels or multiple systems.

A diagnosis that carries a meaningful future risk of kidney disease may make living kidney donation inappropriate even if kidney tests are currently normal.

Other stable conditions may be approached individually.

This is an area where generic internet rules are particularly unreliable.

The transplant nephrologist may need input from rheumatology or another specialist to determine whether nephrectomy would expose the donor to unacceptable future risk.

Again, the important question is not merely whether the donor feels well today.

It is what their health may look like over decades with one kidney.

Can previous surgery disqualify a kidney donor?

Previous surgery is not automatically disqualifying.

However, extensive abdominal surgery may create scar tissue or anatomical challenges relevant to donor nephrectomy.

The surgeon needs to review the type of operation, location, complications and current anatomy.

Previous kidney or urinary surgery can be particularly relevant.

The safest conclusion comes from surgical evaluation and imaging rather than assumptions based on the name of the old operation.

Is a family history of diabetes enough to disqualify you?

No.

Family history is a risk factor, not a diagnosis.

But it becomes more important when combined with obesity, abnormal glucose, gestational diabetes, hypertension or a young age that leaves many decades for diabetes to develop.

This illustrates KDIGO's broader risk-assessment principle.

No single characteristic necessarily determines the decision.

Multiple modest risk factors can become important when they occur together.

The transplant center is trying to predict lifetime risk, not simply count diagnoses.

Is family history of kidney failure enough to disqualify you?

Again, not automatically.

The cause of the family member's kidney failure matters.

If the disease is hereditary, the potential donor may need additional assessment.

If the relative's kidney failure occurred for a clearly non-hereditary reason, the significance may be different.

This is why identifying the recipient's underlying diagnosis is part of responsible living-donor planning.

If the cause remains uncertain and the donor is biologically related, the transplant team may be more cautious.

What if you are medically suitable but the kidney anatomy is unusual?

Unusual anatomy does not always mean rejection.

People can naturally have more than one renal artery, differences in kidney size or other anatomical variants.

Experienced donor surgeons can operate safely in many of these situations.

But anatomy can become disqualifying if surgery would create excessive risk or if removing one kidney would leave the donor with the less healthy organ.

The donor surgeon therefore has an independent role in evaluation.

A nephrologist may consider the person medically suitable while the surgical team identifies an anatomical concern.

Both assessments matter.

What if the recipient desperately needs the transplant?

Recipient urgency does not cancel donor-safety standards.

This is one of the most difficult emotional realities of living donation.

A family may know that the recipient is deteriorating on dialysis.

The potential donor may feel willing to accept more risk.

But the transplant team has an ethical obligation to protect the donor even when the recipient's situation is serious.

The donor is not simply a source of treatment.

They are a healthy person undergoing elective major surgery.

A responsible transplant program may therefore say no even when everyone involved strongly wants the transplant to proceed.

This can be emotionally devastating.

It is nevertheless fundamental to ethical living donation.

The costs of evaluation should not influence medical eligibility

Financial pressure can distort transplant decisions.

A family that has already paid for flights, accommodation or preliminary services may feel that the donor “has to” be accepted.

That should never happen.

Medical eligibility must remain independent of the amount already spent.

Patients considering treatment abroad should therefore understand what is included before travelling.

Our kidney transplant surgery cost page addresses the treatment-cost side separately from donor eligibility.

Keeping these questions separate is important.

Price does not determine medical suitability.

A more expensive package cannot make an unsafe donor safe.

A cheaper package should never achieve its price by reducing donor evaluation.

Choosing a hospital for donor assessment

When comparing transplant hospitals, patients should ask how the donor pathway is organized, not just how many transplant operations the hospital performs.

The donor needs independent medical assessment, surgical review, psychosocial evaluation and access to specialists when results are uncertain.

The hospital should be able to explain why a candidate is being accepted, deferred or rejected.

It should also have a clear plan for follow-up after donation.

For international patients, legal and administrative expertise matters too.

A technically capable hospital still needs to comply with the national transplant framework.

Organ Transplant Abroad also publishes a partner disclosure so patients can distinguish hospital relationships from independent medical evidence.

Donor rejection should protect the donor, not punish them

Families sometimes use language such as “failed the donor tests.”

That wording can be unnecessarily harmful.

The person has not failed.

The evaluation discovered that donation may not be the safest or legally appropriate path.

A potential donor may already feel guilt about being unable to help a loved one.

Clinical communication should make it clear that safety decisions are not moral judgments.

No one owes another person a kidney.

A person who wants to donate but cannot safely do so has not failed the recipient.

This framing is especially important where family expectations are strong.

What should you do if you are disqualified?

The first step is to ask what category the decision belongs to.

Was the issue permanent donor-safety risk?

Was it temporary?

Was more testing required?

Was the donor healthy but incompatible with the recipient?

Was the problem legal or ethical rather than medical?

The answer determines the next step.

If an acute infection caused temporary deferral, treatment and reassessment may be appropriate.

If the issue is significant chronic kidney disease, proceeding elsewhere may expose the donor to unacceptable harm.

If incompatibility is the problem, a regulated paired-exchange pathway may be relevant in some healthcare systems.

If the barrier is legal, medical testing cannot override the law.

Understanding the reason is far more useful than simply hearing “approved” or “rejected.”

A practical classification of common donor findings

This is why an article titled “what disqualifies you” needs more nuance than a list of diseases.

The transplant decision exists on a spectrum.

Kidney donation abroad: what disqualification means before travel

For an international patient, donor rejection can become much more disruptive because flights, visas, accommodation, work leave and family arrangements may already have been organized.

The safest approach is to identify as many obvious barriers as possible before travel.

That does not mean promising remote donor approval.

Final eligibility often depends on testing performed or verified by the transplant center.

Instead, the purpose of pre-travel review is risk reduction.

A complete medical history can identify issues that deserve investigation.

Relationship documentation can reveal whether an ethics pathway is required.

Existing kidney tests can show whether basic renal function needs clarification.

The patient can then travel with a realistic understanding of what remains unresolved.

Our transplant destinations section should be used to understand destination pathways, while the actual donor decision remains with the authorized transplant program.

Red flags in international donor screening

Patients should be cautious if a service promises that a donor is “100% approved” from only a blood type and creatinine result.

That is not a complete donor evaluation.

Likewise, a program should not guarantee that health problems will be ignored because the recipient is paying privately.

Medical standards do not become optional in self-pay transplantation.

Another serious warning sign is any suggestion that relationship documentation, ethics review or financial circumstances should be hidden.

A legitimate pathway should survive regulatory scrutiny.

Our ethical sourcing policy is relevant here because legal living-donor transplantation must be kept clearly separate from organ commerce.

Final answer: what would disqualify you from donating a kidney?

What would disqualify you from donating a kidney is ultimately any medical, surgical, psychosocial, ethical or legal factor that makes living donation unacceptably risky or inappropriate.

Major examples include significant kidney disease or inadequate kidney function, uncontrolled hypertension, certain diabetes profiles, active or incompletely treated high-risk malignancy, unresolved symptomatic infection, unsafe cardiovascular or surgical risk, uncontrolled serious psychiatric illness, donor coercion and illegal payment for an organ.

Other findings are not necessarily automatic exclusions.

Obesity, controlled hypertension, some previous cancers, kidney-stone history and other borderline conditions may require individualized assessment.

A potential donor can also be medically healthy yet incompatible with the intended recipient or unable to proceed through a particular country's legal pathway.

KDIGO therefore recommends comprehensive risk assessment rather than deciding from a single characteristic, while transplant regulations and policies define additional mandatory requirements.

For patients considering Türkiye, medical donor selection is supplemented by formal relationship and ethics rules under the national transplant framework.

The safest question is therefore not simply, “Do I have one condition on a disqualification list?”

It is:

“After reviewing my complete health, lifetime kidney risk, compatibility and legal pathway, does the authorized transplant team believe donation is acceptably safe and appropriate?”

This guide explains what would disqualify you from donating a kidney, separating clear exclusions from temporary problems and conditions that require individual assessment. It covers kidney function, urine abnormalities, hypertension, diabetes, obesity and kidney donor weight requirements, cancer, infections, kidney stones, inherited kidney disease, cardiovascular health, mental health, smoking, pregnancy and donor safety. It also explains why being rejected as a donor does not necessarily mean you are unhealthy, how transplant centers assess borderline cases, and how medical eligibility differs from legal eligibility when considering living kidney transplantation abroad, including the regulated pathway in Türkiye.